🇺🇸 FDA
Patent

US 6617110

Cells immortalized with telomerase reverse transcriptase for use in drug screening

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6617110 (Cells immortalized with telomerase reverse transcriptase for use in drug screening) held by The Regents of the University of Technology Office of Technology Transfer expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of Technology Office of Technology Transfer
Grant date
Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K38/00, A61K39/00, A61K48/00, A61P